453 related articles for article (PubMed ID: 29165853)
1. Past-year Prescription Drug Monitoring Program Opioid Prescriptions and Self-reported Opioid Use in an Emergency Department Population With Opioid Use Disorder.
Hawk K; D'Onofrio G; Fiellin DA; Chawarski MC; O'Connor PG; Owens PH; Pantalon MV; Bernstein SL
Acad Emerg Med; 2018 May; 25(5):508-516. PubMed ID: 29165853
[TBL] [Abstract][Full Text] [Related]
2. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Prescription Drug Monitoring Programs and Prescribing Guidelines on Emergency Department Opioid Prescribing: A Multi-Center Survey.
Pomerleau AC; Nelson LS; Hoppe JA; Salzman M; Weiss PS; Perrone J
Pain Med; 2017 May; 18(5):889-897. PubMed ID: 26995800
[TBL] [Abstract][Full Text] [Related]
4. Evaluating Emergency Department Opioid Prescribing Behaviors After Education About Mandated Use of the Pennsylvania Prescription Drug Monitoring Program.
Martello J; Cassidy B; Mitchell A
J Addict Nurs; 2018; 29(3):196-202. PubMed ID: 30180006
[TBL] [Abstract][Full Text] [Related]
5. The utility of a statewide prescription drug-monitoring database vs the Current Opioid Misuse Measure for identifying drug-aberrant behaviors in emergency department patients already on opioids.
Wilson MP; Cucciare MA; Porter A; Chalmers CE; Mullinax S; Mancino M; Oliveto AH
Am J Emerg Med; 2020 Mar; 38(3):503-507. PubMed ID: 31221474
[TBL] [Abstract][Full Text] [Related]
6. Impact of a Mandatory Prescription Drug Monitoring Program Check on Emergency Department Opioid Prescribing Rates.
Watson CJ; Ganetsky M; Burke RC; Dizitzer Y; Leventhal EL; Boyle KL
J Med Toxicol; 2021 Jul; 17(3):265-270. PubMed ID: 33821434
[TBL] [Abstract][Full Text] [Related]
7. Associations between statewide prescription drug monitoring program (PDMP) requirement and physician patterns of prescribing opioid analgesics for patients with non-cancer chronic pain.
Lin HC; Wang Z; Boyd C; Simoni-Wastila L; Buu A
Addict Behav; 2018 Jan; 76():348-354. PubMed ID: 28898808
[TBL] [Abstract][Full Text] [Related]
8. Mapping prescription drug monitoring program data to self-report measures of non-medical prescription opioid use in community pharmacy settings.
Charron E; Brooks JH; Peterson KT; Akinwolere OG; Winhusen T; Cochran G
Res Social Adm Pharm; 2023 Aug; 19(8):1171-1177. PubMed ID: 37142474
[TBL] [Abstract][Full Text] [Related]
9. Effect of a legislative mandate on opioid prescribing for back pain in the emergency department.
Khobrani M; Perona S; Patanwala AE
Am J Emerg Med; 2019 Nov; 37(11):2035-2038. PubMed ID: 30824275
[TBL] [Abstract][Full Text] [Related]
10. A comparison of an opioid abuse screening tool and prescription drug monitoring data in the emergency department.
Weiner SG; Horton LC; Green TC; Butler SF
Drug Alcohol Depend; 2016 Feb; 159():152-7. PubMed ID: 26743334
[TBL] [Abstract][Full Text] [Related]
11. The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016-2020.
Adalbert JR; Syal A; Varshney K; George B; Hom J; Ilyas AM
BMC Health Serv Res; 2023 Apr; 23(1):364. PubMed ID: 37046254
[TBL] [Abstract][Full Text] [Related]
12. Optimal Implementation of Prescription Drug Monitoring Programs in the Emergency Department.
Elder JW; DePalma G; Pines JM
West J Emerg Med; 2018 Mar; 19(2):387-391. PubMed ID: 29560070
[TBL] [Abstract][Full Text] [Related]
13. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning.
Martins SS; Ponicki W; Smith N; Rivera-Aguirre A; Davis CS; Fink DS; Castillo-Carniglia A; Henry SG; Marshall BDL; Gruenewald P; Cerdá M
Int J Drug Policy; 2019 Dec; 74():174-180. PubMed ID: 31627159
[TBL] [Abstract][Full Text] [Related]
14. The Effect of a Statewide Mandatory Prescription Drug Monitoring Program on Opioid Prescribing by Emergency Medicine Providers Across 15 Hospitals in a Single Health System.
Suffoletto B; Lynch M; Pacella CB; Yealy DM; Callaway CW
J Pain; 2018 Apr; 19(4):430-438. PubMed ID: 29241835
[TBL] [Abstract][Full Text] [Related]
15. Provider Prescription Drug Monitoring Program Utilization and Self-Auditing-A Pilot Study.
Brown WC; Whitted K
J Dr Nurs Pract; 2020 Jul; 13(2):142-147. PubMed ID: 32817503
[TBL] [Abstract][Full Text] [Related]
16. Physician attitudes and experiences with Maryland's prescription drug monitoring program (PDMP).
Lin DH; Lucas E; Murimi IB; Jackson K; Baier M; Frattaroli S; Gielen AC; Moyo P; Simoni-Wastila L; Alexander GC
Addiction; 2017 Feb; 112(2):311-319. PubMed ID: 27658522
[TBL] [Abstract][Full Text] [Related]
17. Usability of the Massachusetts Prescription Drug Monitoring Program in the Emergency Department: A Mixed-methods Study.
Poon SJ; Greenwood-Ericksen MB; Gish RE; Neri PM; Takhar SS; Weiner SG; Schuur JD; Landman AB
Acad Emerg Med; 2016 Apr; 23(4):406-14. PubMed ID: 26806310
[TBL] [Abstract][Full Text] [Related]
18. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
[TBL] [Abstract][Full Text] [Related]
19. Mandatory Review of Prescription Drug Monitoring Program Before Issuance of a Controlled Substance Results in Overall Reduction of Prescriptions Including Opioids and Benzodiazepines.
Manders L; Abd-Elsayed A
Pain Physician; 2020 Jun; 23(3):299-304. PubMed ID: 32517396
[TBL] [Abstract][Full Text] [Related]
20. Changes in opioid agonist treatment initiation among people prescribed opioids for pain following voluntary and mandatory prescription drug monitoring program implementation: A time series analysis.
Picco L; Xia T; Bell JS; Pearce C; Buchbinder R; Lubman DI; Nielsen S
Drug Alcohol Rev; 2023 Nov; 42(7):1639-1646. PubMed ID: 37798947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
